#SJMB03 - Twitter Hashtag

over 3 years ago

Truly path-breaking research @DrAmarGajjar 👏👏👏👏🙏🙏 #SJMB96 and #SJMB03 both studies have lead improved outcome of children with #Medulloblastoma and have lead to better understanding of biology of these tumors 👇

Amar Gajjar @DrAmarGajjar

over 3 years ago

When I started, kids w/ #medulloblastoma often underwent harsh radiation & up to a year of low-dose chemo. #SJMB96 tested adjusted doses of chemo & radiation. Results from the trial were encouraging & gave patients hope for better outcomes. https://t.co/9BNCINIYUE

DrAmarGajjar's tweet photo. When I started, kids w/ #medulloblastoma often underwent harsh radiation & up to a year of low-dose chemo. #SJMB96 tested adjusted doses of chemo & radiation. Results from the trial were encouraging & gave patients hope for better outcomes. https://t.co/9BNCINIYUE https://t.co/d0xkYKDisS

0

41

3

0

4K

0

2

0

326

Amar Gajjar @DrAmarGajjar

over 3 years ago

#SJMB03 found that all WNT & some SHH & Groups 3/4 are low risk. Results furthered our understanding of the tumor’s molecular makeup, allowing us to risk-stratify treatment. They laid the groundwork for #SJMB12 & the newly launched #SJiMB21. https://t.co/GK61fSk6Mb

DrAmarGajjar's tweet photo. #SJMB03 found that all WNT & some SHH & Groups 3/4 are low risk. Results furthered our understanding of the tumor’s molecular makeup, allowing us to risk-stratify treatment. They laid the groundwork for #SJMB12 & the newly launched #SJiMB21. https://t.co/GK61fSk6Mb https://t.co/vm6dNQZeOo

0

18

4

0

2K

Amar Gajjar @DrAmarGajjar

over 3 years ago

"#SJMB03 gave us a more granular understanding of risk that can help determine when to reduce or escalate therapy," said @DrGilesRobinson, PI of #SJiMB21, a study that uses both molecular & clinical risk-based therapy to treat infants with #medulloblastoma https://t.co/dkJnLlGhHv

0

7

0

566

Satya Prakash Yadav @Satyayadav__

almost 4 years ago

Outcomes by Clinical and Molecular Features in Children With #Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial #SJMB03 https://t.co/YXrUWHD4LW

0

2

0

109

Top Tweets for #SJMB03

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users